ÂÜÀòÂÒÂ×

Jonas Dyhrfjeld-Johnsen, PhD has extensive experience in research and development in the field of inner ear diseases, with a focus on drug discovery and translational development. Jonas has held key positions at companies like Sensorion, Rewind Therapeutics, and Acousia Therapeutics GmbH, and has a strong background in neuroscience and biology. Jonas has also conducted research at prestigious institutions such as Harvard Medical School and University of California - Irvine, and holds a Ph.D. in Biology/Neuroscience from the University of Düsseldorf.